Factors Determining the Three-Year Dynamics of Lipid Metabolism Indicators in Residents of a Large Industrial Region of Siberia

QR Code

Factors Determining the Three-Year Dynamics of Lipid Metabolism Indicators in Residents of a Large Industrial Region of Siberia

Aim. To assess the contribution of traditional and socio-economic factors to the development and dynamics of dyslipidemia based on the results of an epidemiological study in a large region of Siberia.Material and methods. Clinical and epidemiological prospective study of the population 35-70 years o...

Full description

Saved in:

Bibliographic Details
Main Authors:	D. P. Tsygankova, E. D. Bazdyrev, E. V. Indukaeva, A. S. Agienko, O. V. Nakhratova, G. V. Artamonova, O. L. Barbarash
Format:	Article
Language:	English
Published:	Столичная издательская компания 2022-01-01
Series:	Рациональная фармакотерапия в кардиологии
Subjects:	dyslipidemia risk factors cardiovascular diseases socio-economic factors
Online Access:	https://www.rpcardio.online/jour/article/view/2631
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Socio-economic determinants of risk of ischemic events: results of three-year clinical and epidemiological surveillance
by: D. Yu. Sedykh, et al.
Published: (2024-07-01)

Parameters of the Infrastructure of the Residential Area and Their Relationship with Cardiovascular Risk Factors
by: T. A. Mulerova, et al.
Published: (2022-09-01)

Prevalence of CHD possibly presence in a sample epidemiological study, taking into account the socio-economic characteristics of the participants
by: A. S. Agienko, et al.
Published: (2021-06-01)

Changes in Cardiovascular Risk Factors in Residents of the Siberian Region (According to Epidemiological Studies)
by: G. V. Artamonova, et al.
Published: (2021-07-01)

Prevalence of a combination of hypertension and dyslipidemia among the adult population of a large East Siberian region
by: Yu. I. Grinshtein, et al.
Published: (2021-07-01)

Time course of changes in lipid profile measures in patients with early psoriatic arthritis during adalimumab therapy
by: E. I. Markelova, et al.
Published: (2019-11-01)

RELATIONSHIPS BETWEEN LIPID AND IMMUNE DISORDERS AT VARIOUS STAGES OF DEVELOPING EXPERIMENTAL DYSLIPIDEMIA
by: E. G. Lobanova, et al.
Published: (2014-07-01)

Dietary patterns and their relationship with main cardiovascular risk factors in coal industry workers
by: D. P. Tsygankova, et al.
Published: (2025-05-01)

Cardiovascular risk factors in children with hereditary loading
by: A. A. Muratov, et al.
Published: (2020-03-01)

Association of smoking with coronary artery disease depending on other cardiovascular risk factors
by: E. D. Bazdyrev, et al.
Published: (2021-04-01)

THIRTY-YEAR CHANGES IN AVERAGE BLOOD LIPIDS LEVELS IN POPULATIONS OF THE RUSSIAN FEDERATION AND THE USA
by: S. A. Shalnova, et al.
Published: (2018-03-01)

Diabetic retinopathy and dyslipidemia among patients with type 2 diabetes mellitus in the Jazan endocrine and diabetes center: A case-control study
by: Mansor Bayydih, et al.
Published: (2025-06-01)

Implemented models and perspectives of managing lipid metabolism disorders. Concept of rare lipid disease centers
by: A. S. Alieva, et al.
Published: (2021-07-01)

Associations of changes in lipid metabolism parameters and the severity of COVID-19 infection in Novosibirsk residents
by: A. A. Karaseva, et al.
Published: (2022-09-01)

Hemorheological parameters in patients with arterial hypertension and lipid metabolism disorders
by: E. D. Abrashkina, et al.
Published: (2010-02-01)

Lipitension and cardiometabolic risk factors in young people
by: A. V. Sineglazova, et al.
Published: (2024-05-01)

Organization of lipid centers operation in the Russian Federation — new opportunities
by: M. V. Ezhov, et al.
Published: (2021-07-01)

Cardiovascular system status of long-livers in Moscow: the prevalence of cardiovascular diseases and their risk factors
by: K. A. Eruslanova, et al.
Published: (2021-04-01)

Atherogenic index of plasma as an additional marker of adverse cardiovascular outcomes
by: Yu. I. Grinshtein, et al.
Published: (2022-06-01)

PCSK9 inhibitors for in-hospital treatment of patients with acute coronary syndrome and severe lipid metabolism disorders
by: O. L. Barbarash, et al.
Published: (2020-09-01)

Gender and age features of dyslipidemia in the population of the Nizhny Novgorod region
by: N. Yu. Borovkova, et al.
Published: (2023-11-01)

Three-year dynamics and unsolved problems of lipid-lowering therapy
by: V. A. Sergeeva
Published: (2015-11-01)

INFLUENCE OF ENALAPRIL, DIGOXIN, ATENOLOL AND DILTIAZEM ON LIPID PEROXIDATION IN EXPERIMENTAL MODEL OF COMPLEX METABOLIC DISORDERS
by: A. A. Usanova, et al.
Published: (2016-01-01)

Coronary heart disease and risk factors in elderly population
by: A. E. Imaeva, et al.
Published: (2016-04-01)

Intensification of lipid-lowering therapy in very high-risk patients: potential of combination with PCSK9 inhibitors
by: D. Yu. Sedykh, et al.
Published: (2022-07-01)

Increment of the effectiveness of treating hypertension and dyslipidemia using a triple fixed-dose combination and the vascular age concept
by: O. V. Tsygankova, et al.
Published: (2020-09-01)

Polymorbidity and indicators of carbohydrate, lipid and purine metabolism in patients with arterial hypertension
by: Yu. A. Nikolaev, et al.
Published: (2021-08-01)

LIPID-LOWERING THERAPY IN OUTPATIENT PRACTICE (ACCORDING TO THE ARGO-2 STUDY)
by: N. M. Akhmedzhanov, et al.
Published: (2016-05-01)

Clinical Guidelines of the Russian Society for the Study of the Liver, Russian Gastroenterological Association, Russian Society for the Prevention of Non-Communicable Diseases, Russian Association of Endocrinologists, Russian Scientific Medical Society of Therapists, National Society of Preventive Cardiology, Russian Association of Gerontologists and Geriatricians on Non-Alcoholic Fatty Liver Disease
by: V. T. Ivashkin, et al.
Published: (2025-03-01)

Eurasian clinical guidelines for the prevention of cardiovascular diseases in childhood and adolescence (2023)
by: O. A. Kislyak, et al.
Published: (2023-10-01)

INFLUENCE OF NEUROTIC AND AFFECTIVE DISORDERS ON FORMATION OF PREDICTORS OF ISCHEMIC HEART DISEASE AND DISORDERS OF CARBOHYDRATE AND LIPID METABOLISM
by: N. P. Garganeyeva, et al.
Published: (2015-10-01)

Sex and age specificities of the dynamics of anthropometric indicators characterizing obesity (according to a prospective epidemiological research)
by: D. P. Tsygankova, et al.
Published: (2024-01-01)

Migration Attitudes of Graduate Students : on the Issue of “Brain Drain”
by: Sobkin V.S., et al.
Published: (2020-11-01)

EFFICACY OF PHYSICAL TRAINING AND ANALYSIS OF LIPID-LOWERING THERAPY IN PATIENTS WITH ISCHEMIC HEART DISEASE AFTER ACUTE CORONARY INCIDENTS
by: D. M. Aronov, et al.
Published: (2016-01-01)

Screening of depression with an assessment of the socioeconomic status of patients in the primary care network in the large industrial city of Eastern Siberia
by: R. D. Peskovets, et al.
Published: (2020-07-01)

Lipid profile changes after the acute COVID-19 period. Sub-analysis of the International Registry "Dynamics Analysis of Comorbidities in SARS-CoV-2 Survivors" (AKTIV SARS-CoV-2)" (12-month follow-up)
by: G. P. Arutyunov, et al.
Published: (2024-04-01)

Association of impaired myocardial flow reserve with risk factors for cardiovascular diseases in patients with nonobstructive coronary artery disease
by: A. N. Maltseva, et al.
Published: (2023-03-01)

The effect of yoga practice on lipid profiles in patients with chronic heart failure
by: T.M. Babkina, et al.
Published: (2022-06-01)

LIPID PROFILE PARAMETERS IN THE PERSONS OF YAKUT ETHNICITY WITH METABOLIC SYNDROME COMORBID WITH RESPIRATORY PATHOLOGY
by: E. P. Borisova, et al.
Published: (2015-06-01)

Combined hypolipidemic therapy in patients who failed to achieve target values of the lipidogram. Possibilities of ezetimibe
by: N. V. Fedorova, et al.
Published: (2021-06-01)